MedTrace Logo

Biomarkers for Obstructive Sleep Apnea

NCT00834509 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 181

Last updated 2017-04-18

No results posted yet for this study

Summary

The purpose of the study is to:

* recruit subjects with untreated sleep apnea; assess overnight changes in their blood and urine chemicals
* review the overnight changes in blood and urine chemicals after they have been treated for sleep apnea
* assess the overnight changes in blood and urine chemicals in healthy individuals with no sleep problems
* compare the amount of fat in the belly using a Magnetic Resonance Imaging (MRI) scanner on all subjects

Conditions

  • Obstructive Sleep Apnea (OSA)

Interventions

DEVICE

CPAP

Use CPAP for 4-6 weeks as clinically prescribed.

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • University of Pennsylvania

    lead OTHER

Principal Investigators

  • Allan I Pack, MD · University of Pennsylvania

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2015-02-01
Completion
2015-02-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00834509 on ClinicalTrials.gov